Title page
Contents
Abstract 2
1. Introduction 3
2. Related Literature 5
2.1. Access to science and scientific output 6
2.2. Access to science and follow-on local innovation 7
3. Data and Variables 10
3.1. The Hinari programme 10
3.2. Data 11
3.3. Definition of variables 15
4. Empirical Strategy 16
5. Empirical Analysis 18
5.1. Hinari impact on publication output 18
5.2. Hinari impact on clinical trials 19
5.3. Robustness 20
5.4. Effect heterogeneity 21
5.5. Additional results 22
6. Conclusion 24
References 27
Online Appendix 61
Table 1. Summary Statistics 43
Table 2. Effect of HINARI on Publication Output 44
Table 3. Effect of HINARI on Publication Output, by the Number of Quarters with Publications 45
Table 4. Effect of HINARI on Publication Output by Group 47
Table 5. Effect of HINARI on Publication Output by World Regions 48
Table 6. Summary Statistics 49
Table 7. Effect of HINARI on Clinical Trial Output 50
Table 8. Effect of HINARI on Clinical Trial Output, by the Number of Quarters with Trials 51
Table 9. Effect of HINARI on Clinical Trial Output by Group 53
Table 10. Effect of HINARI on Clinical Trial Output by World Regions 54
Table 11. Summary Statistics 55
Table 12. Effect of HINARI on Patents Citation - DiD 56
Table 13. Effect of HINARI on Patent Citations 57
Table 14. Effect of HINARI on Patent Citations by the Number of Quarters with Citations 58
Table 15. MAG Health scientific publication classification by Web Of Science field 61
Fig.1. Cumulative rate of the Hinari programme adoption 41
Fig.2. Hinari institutions by country 42
Fig.3. Event Study on Publication Output 46
Fig.4. Event Study on Clinical Trial Output 52
Fig.5. Event Study on Patent Citations - Baseline 59
Fig.6. Event Study on Patent Citations 60